Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$70,780,000
+$7,482,260 QoQ
Shares Held
2,000,000
-12.5% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
17.60%
of 13F equity value
Holder Rank
#50
of 497 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BlackBarn Capital Partners LP holds $106,186,000 across 3 Biotechnology names. ROIV ranks #1 (66.7% of the industry book) .
All Filings in ROIV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,780,000 | 2,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $63,297,740 | 2,285,117 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $66,929,310 | 3,084,300 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $66,572,000 | 4,400,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $52,123,750 | 4,625,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $47,927,500 | 4,750,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $48,798,750 | 4,125,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $46,160,000 | 4,000,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,767,000 | 3,100,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,032,260 | 1,900,594 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $17,406,500 | 1,550,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||